Based on data from the past 90 days ending December 12, 2025, Kyverna Therapeutics's three largest insider shareholders are Director Fred E Cohen (4.54Mn shares), Director Beth C Seidenberg (752.62K shares), Other Ventures Iii Gp, Llc Northpond (450.00K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Fred E Cohen | 4,540,558 | 02 Jun, 2025 | |
| Sciences, Inc. Gilead | 4,126,119 | 13 Feb, 2024 | |
| Capital Life Sciences Investors, Llc Bain | 3,163,868 | 14 Feb, 2024 | |
| Beth C Seidenberg | 752,618 | 02 Jun, 2025 | |
| Biopartners Fund I, L.P. Westlake | 735,984 | 14 Feb, 2024 | |
| Ventures Iii Gp, Llc Northpond | 450,000 | 12 Feb, 2024 | |
| Ryan Alexander Jones | Chief Financial Officer | 55,950 | 15 Apr, 2025 |
| Karen Marie Walker | Chief Technology Officer | 22,636 | 15 Apr, 2025 |
| Mert Aktar | 16,634 | 02 Jun, 2025 | |
| Christi Shaw | 16,634 | 02 Jun, 2025 | |
| Ian T Clark | 16,634 | 02 Jun, 2025 | |
| Daniel K Spiegelman | 16,634 | 02 Jun, 2025 | |
| Ventures, Llc Vida | 583 | 14 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 29 May, 2025 | Daniel K Spiegelman | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Beth C Seidenberg | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Christi Shaw | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Mert Aktar | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Ian T Clark | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 29 May, 2025 | Fred E Cohen | Common Stock | A | 16,634 | $0.00 | 16,634 | D | A |
| 11 Apr, 2025 | Ryan Alexander Jones | Common Stock | A | 12,000 | $0.00 | 55,950 | D | A |
| 11 Apr, 2025 | Karen Marie Walker | Common Stock | A | 13,000 | $0.00 | 22,636 | D | A |
| 06 Jun, 2024 | Karen Marie Walker | Common Stock | A | 9,636 | $4.42 | 9,636 | D | M |
| 28 May, 2024 | Ryan Alexander Jones | Common Stock | A | 10,870 | $0.73 | 36,804 | D | M |
| 28 May, 2024 | Ryan Alexander Jones | Common Stock | A | 7,146 | $0.73 | 43,950 | D | M |
| 12 Feb, 2024 | Ventures Iii Gp, Llc Northpond | Common Stock | A | 2,805,426 | - | 2,805,426 | I | C |
| 12 Feb, 2024 | Capital Life Sciences Investors, Llc Bain | Common Stock | A | 2,713,868 | - | 2,713,868 | I | C |
| 12 Feb, 2024 | Beth C Seidenberg | Common Stock | A | 3,787,940 | - | 3,787,940 | I | C |
| 12 Feb, 2024 | Fred E Cohen | Common Stock | A | 4,523,924 | - | 4,523,924 | I | C |
| 12 Feb, 2024 | Ventures, Llc Vida | Common Stock | A | 4,523,924 | - | 4,523,924 | I | C |
| 12 Feb, 2024 | Sciences, Inc. Gilead | Common Stock | A | 3,216,119 | - | 3,216,119 | D | C |
| 12 Feb, 2024 | Biopartners Fund I, L.P. Westlake | Common Stock | A | 3,787,940 | - | 3,787,940 | I | C |
| 12 Feb, 2024 | Biopartners Fund I, L.P. Westlake | - | - | 3,787,940 | I | |||
| 12 Feb, 2024 | Capital Life Sciences Investors, Llc Bain | Common Stock | A | 450,000 | $22.00 | 3,163,868 | I | P |